Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program

Diabetes Care

Volumn 30, Issue 10, 2007, Pages 2453-2457

  Herman, William H ^a,b   Ma, Yong ^b   Uwaifo, Gabriel ^c   Haffner, Steven ^d   Kahn, Steven E ^e   Horton, Edward S ^f   Lachin, John M ^b   Montez, Maria G ^g   Brenneman, Tina ^b   Barrett Connor, Elizabeth ^h  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c MEDSTAR RESEARCH INSTITUTE   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f JOSLIN DIABETES CENTER   (United States)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CELL FUNCTION; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ETHNICITY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HEMATOCRIT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; OBESITY; PROPHYLAXIS; RACE DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS; EDUCATIONAL STATUS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEALTH STATUS; HEMOGLOBIN A, GLYCOSYLATED; HISPANIC AMERICANS; HUMANS; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; MINORITY GROUPS;

EID: 35148859728     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2003     Document Type: Article

References (27)

1. Nathan DM, Singer DE, Hurxthal K, Goodson JD: The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 310:341-346, 1984
2. Goldstein DE, Little RR, Wiedmeyer H-M, England JD, McKenzie EM: Glycated hemoglobin: methodologies and clinical applications. Clin Chem 32 (Suppl. 10):B64-B70, 1986
3. Kirk JK, Bell RA, Bertoni AG, Arcury TA, Quandt SA, Goff DC, Narayan KMV: Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes. Ann Pharmacother 39:1489-1501, 2005
4. Summerson JH, Konen JC, Dignan MB: Race-related differences in metabolic control among adults with diabetes. South Med J 85:953-956, 1992
5. Wisdom K, Fryzek JP, Havstad SL, Anderson RM, Dreiling MC, Tilley BC: Comparison of laboratory test frequency and test results between African-Americans and whites with diabetes: opportunity for improvement: findings from a large urban health maintenance organization. Diabetes Care 20:971-977, 1997
6. Gary TL, McGuire M, McCauley J, Brancati FL: Racial comparisons of health care and glycemic control for black and white diabetic adults in an urban managed care organization. Dis Management 7:25-34, 2004
7. Brown AF, Gerzoff RB, Karter AJ, Gregg E, Safford M, Waitzfelder B, Beckles GLA, Brusuelas R, Mangione CM, the TRIAD Study Group: Health behaviors and quality of care among Latinos with diabetes in managed care. Am J Public Health 93:1694-1698, 2003
8. Brown AF, Gregg EW, Stevens MR, Karter AJ, Weinberger M, Safford MM, Gary TL, Caputo DA, Waitzfelder B, Kim C, Beckles GL: Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 28:2864-2870, 2005
9. Eberhardt MS, Lackland DT, Wheeler FC, German RR, Teutsch SM: Is race related to glycemic control? An assessment of glycosylated hemoglobin in two South Carolina communities. J Clinical Epidemiol 47:1181-1189, 1994
10. Saaddine JB, Fagot-Campagna A, Rolka D, Narayan KMV, Geiss L, Eberhardt M, Flegal KM: Distribution of HbA1C levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. Diabetes Care 25:1326-1330, 2002
11. The Diabetes Prevention Program Research Group: The Diabetes Prevention Program: baseline characteristics of the randomized cohort. Diabetes Care 23:1619-1629, 2000
12. Hocking RR: The Analysis of Linear Models. Belmont, CA, Brooks/Cole Publishing, 1985
13. Shapiro SS, Wilk MB: An analysis of variance test for normality (complete samples). Biometrika 52:591-611, 1965
14. White H: A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrics 48:817-838, 1980
15. Holm S: A simple sequentially rejective Bonferroni test procedure. Scandinavian Journal of Statistics 6:65-70, 1979
16. The DCCT Research Group: Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care 10:1-19, 1987
17. Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ: Unexplained variability of glycated hemoglobin in nondiabetic subjects not related to glycaemia. Diabetologia 33:208-215, 1990
18. Meigs JB, Nathan DM, Cupples LA, Wilson PW, Singer DE: Tracking of glycated hemoglobin in the original cohort of the Framingham-Heart Study. J Clin Epidemiol 49:411-417, 1996
19. Strickland MH, Paton RC, Wales JK: Hemoglobin A1c concentrations in men and women with diabetes. Br Med J 289:733, 1984
20. Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI; Postmenopausal Estrogen/ Progestin Intervention Trial: Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab 88:1646-1652, 2003
21. Araneta MR, Barret-Connor E: Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and white women. Obesity Research 13:1458-1465, 2005
22. Gould BJ, Davie SJ, Yudkin JS: Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clinica Chimica Acta 260:49-64, 1997
23. Delpierre G, Collard F, Fortpied J, Van Schaftingen E: Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes. Biochem J 365:801-808, 2002
24. Snieder H, Sawtell PA, Ross L, Walker J, Spector TD, Leslie RD: A1C levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 50:2858-2863, 2001
25. Cohen RM, Snieder H, Lindsell CJ, Beyan H, Hawa MI, Blinko S, Edwards R, Spector TD, Leslie RDG: Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of A1C in nondiabetic twins. Diabetes Care 29:1739-1743, 2006
26. Peterson CM, Jones RL, Koenig RJ, Melvin ET, Lehrman ML: Reversible hematologic sequelae of diabetes mellitus. Ann Intern Med 86:425-429, 1977
27. Virtue MA, Furne JK, Nuttall FQ, Levitt MD: Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 27:931-935, 2004